Anwar H,Mukhtar I,Muzaffar H,Irfan S,Saleem S,Ijaz F,Akash MSH F .2024 .. , : 25-50.
Averina OV,Poluektova EU,Marsova MV,Danilenko VN .2021 .Biomarkers and utility of the antioxidant potential of probiotic Lactobacilli and Bifidobacteria as representatives of the human gut microbiota. Biomedicines, 9(10) : 1340.
Biegel A,Knütter I,Hartrodt B,Gebauer S,Theis S,Luckner P .2006 .The renal type H+/peptide symporter PEPT2: structure-affinity relationships. Amino acids, 31 : 137-56.
Brandsch M,Knütter I,Bosse‐Doenecke E .2008 .Pharmaceutical and pharmacological importance of peptide transporters. J. Pharm. Pharmacol, 60(5) : 543-585.
Bu G,Parrish S,Gleason PR,Nielsen DR,Nannenga BL .2020 .Heterologous expression and purification of the bicarbonate transporter BicA from Synechocystis sp. PCC 6803. Protein Expr. Purif, 175 : 105716.
CambridgeSoft .1986 .CambridgeSoft Corp. ChemDraw Ultra 12.0, 0(Copyright) : .
Chen HQ,Gong JY,Xing K,Liu MZ,Ren H,Luo JQ .2022 .Pharmacomicrobiomics: exploiting the drug-microbiota interactions in antihypertensive treatment. Front. Med, 8 : 742394.
Coker O .2023 .Non-bacteria microbiome (virus, fungi, and archaea. gastrointestinal cancer, : 91-106.
Colella M,Charitos IA,Ballini A,Cafiero C,Topi S,Palmirotta R,Santacroce L .2023 .Microbiota revolution: How gut microbes regulate our lives. WJG, 29(28) : 4368.
Coniglio MV,Luna MJ,Provensal P,Watson S,Ortiz ME,Ludueña HR,Magnoli AP .2023 .The Impact of Saccharomyces cerevisiae var. Boulardii RC009 on productive parameters in weaned calves and cull cows. ABRs, 13 : 1-6.
Di Pierro F .2021 .Gut microbiota parameters potentially useful in clinical perspective. Microorganisms, 9(11) : 2402.
Demishtein K,Reifen R,Shemesh M .2019 .Antimicrobial properties of magnesium open opportunities to develop healthier food. Nutrients, 11(10) : 2363.
Dobson PD,Kell DB .2008 .Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?. Nat. Rev. Drug Discov, 7(3) : 205-20.
Doestzada M,Vila AV,Zhernakova A,Koonen DP,Weersma RK,Touw DJ,Kuipers F,Wijmenga C,Fu J .2018 .Pharmacomicrobiomics: a novel route towards personalized medicine?. Protein Cell, 9(5) : 432-445.
Eberhardt J,Santos-Martins D,Tillack AF,Forli S .2021 .New docking methods, expanded force field, and python bindings. J. Chem. Inf. Model, 61(8) : 3891-3898.
Effinger A,O'Driscoll CM,McAllister M,Fotaki N .2019 .Impact of gastrointestinal disease states on oral drug absorptionimplications for formulation design-a PEARRL review. J. Pharm. Pharmacol, 71(4) : 674-698.
Ekici S,Demirci M,Dülger D,Yiğin A .2023 .The Quinolone Resistance Genes in the Bacteriophage DNA Fractions in the Healthy Calf Stool Samples Via qPCR. Kafkas Univ. Vet, 29(1) : 49-54.
El Aidy S,Van Den Bogert B and Kleerebezem M .2015 .The small intestine microbiota, nutritional modulation and relevance for health. Curr. Opin. Biotechnol, 32 : 14-20.
Hollister EB,Gao C,Versalovic J .2014 .Compositional and functional features of the gastrointestinal microbiome and their effects on human health. J. Gastroenterol, 146(6) : 1449-58.
Fei YJ,Sugawara M,Liu JC,Li H.,Ganapathy V,Ganapathy ME,Leibach FH .2000 .cDNA structure, genomic organization, and promoter analysis of the mouse intestinal peptide transporter PEPT1. Biochim. Biophys. Acta Gene Struct. Expression, 1492(1) : 145-154.
Ferreira LG,Dos Santos RN,Oliva G,Andricopulo AD .2015 .Molecular docking and structure-based drug design strategies. Molecules, 20(7) : 13384-13421.
Gao K,Wang PX,Mei X,Yang T,Yu K .2024 .Untapped potential of gut microbiome for hypertension management. Gut Microbes, 16(1) : 2356278.
Goh EB,Siino DF,Igo MM .2004 .The Escherichia coli tppB (ydgR) gene represents a new class of OmpR-regulated genes. J. Bacteriol, 186(12) : 4019-24.
Gu S,Chen D,Zhang J-N,Lv X,Wang K,Duan L-P .2013 .Bacterial community mapping of the mouse gastrointestinal tract. PloS one, 8(10) : e74957.
Harder D,Stolz J,Casagrande F,Obrdlik P,Weitz D,Fotiadis D .2008 .DtpB (YhiP) and DtpA (TppB, YdgR) are prototypical proton‐dependent peptide transporters of Escherichia coli. The FEBS J, 275(13) : 3290-8.
Jackson R and Bellamy M .2015 .Antihypertensive drugs. BJA Education, 15(6) : 280-5.
Jóźwiak-Bebenista M,Nowak JZ .2014 .Paracetamol: mechanism of action, applications and safety concern. Acta Pol. Pharm, 71(1) : 11-23.
Li D,Chen H,Mao B,Yang Q,Zhao J,Gu Z .2017 .Microbial biogeography and core microbiota of the rat digestive tract. Sci. Rep, 7(1) : 1-16.
Lorca GL,Barabote RD,Zlotopolski V,Tran C,Winnen B,Hvorup RN,Stonestrom AJ,Nguyen E,Huang LW,Kim DS,Saier MH .2007 .Transport capabilities of eleven gram-positive bacteria: comparative genomic analyses. Biochim. Biophys. Acta Biomembr, 1768(6) : 1342-66.
Maier L,Pruteanu M,Kuhn M,Zeller G,Telzerow A,Anderson EE .2018 .Extensive impact of non-antibiotic drugs on human gut bacteria. Nature, 10 : 623-8.
Morrison RA,Chong S,Marino AM,Wasserman MA,Timmins P,Moore VA .1996 .Suitability of enalapril as a probe of the dipeptide transporter system: in vitro and in vivo studies. J. Pharm. Res, 13 : 1078-82.
Morris GM,Huey R,Lindstrom W,Sanner MF,Belew RK,Goodsell DS,Olson AJ .2009 .AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem, 30(16) : 2785-2791.
Mukhtar I,Anwar H,Hussain G,Rasul A,Naqvi SAR,Faisal MN,Mustafa I,Malik S,Shaukat A,Mirza OA,Sohail MU .2019 .Detection of Paracetamol as substrate of the gut microbiome. PJPS, 32(2) : 751-757.
Mukhtar I,Anwar H,Iftikhar A,Hashem HE,Ali Q,Siddique F .2022 .Human targeted phenobarbital presents a poor substrate of gut microbiome deciphering new drug targets beyond pharmacokinetic curbs. BMC Pharmacol. Toxicol, 23(1) : 85.
Mussap M,Loddo C,Fanni C,Fanos V .2020 .Metabolomics in pharmacology-a delve into the novel field of pharmacometabolomics. Expert Rev. Clin. Pharmacol, 13(2) : 115-134.
Nielsen CU,Brodin B,Jørgensen FS,Frokjaer S,Steffansen B .2002 .Human peptide transporters: therapeutic applications. Expert Opin. Ther. Pat, 12(9) : 1329-1350.
Nikaido H .2003 .Molecular basis of bacterial outer membrane permeability revisited. J. Mol. Biol, 67(4) : 593-656.
Pizzagalli MD,Bensimon A,Superti‐Furga G .2021 .A guide to plasma membrane solute carrier proteins. The FEBS J, 288(9) : 2784-2835.
Prabhala BK,Aduri NG,Iqbal M,Rahman M,Gajhede M,Hansen PR .2017 .Several hPepT1- transported drugs are substrates of the Escherichia coli proton-coupled oligopeptide transporter YdgR. Microbiol. Res, 168(5) : 443-9.
Rubio-Aliaga I,Daniel H .2008 .Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica, 38(7-8) : 1022-42.
Stojančević M,Bojić G,Al Salami H and Mikov M .2014 .The influence of intestinal tract and probiotics on the fate of orally administered drugs. Curr. Iss Mol. Biol, 16(1) : 55-68.
Subramaniam S,Kamath S,Ariaee A,Prestidge C,Joyce P .2023 .The impact of common pharmaceutical excipients on the gut microbiota. Expert. Opin. Drug. Deliv, 20(10) : 1297-1314.
Sultana N,Naveed S,Arayne MS,Med R&R .2013 .Monitoring of in vitro interaction studies of enalapril with hypoglycemic agents by LC-UV. Chem, 3 : 19-29.
Torres-Carrillo N,Martínez-López E,Torres-Carrillo NM,López-Quintero A,Moreno- Ortiz JM,González-Mercado A,Gutiérrez-Hurtado IA .2023 .Pharmacomicrobiomics and DrugInfection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy. Int. J. Mol. Sci, 24(23) : 17100.
Urttiac A,Sadée W,Johns SJ .2001 .Genomic structure of proton-coupled oligopeptide transporter hPEPT1 and pH-sensing regulatory splice variant. AAPS PharmSciTech, 3(1) : 66-79.
Visualizer DS .2005 .. Accelrys Software Inc, : .
Yusuf D,Davis AM,Kleywegt GJ,Schmitt S .2008 .An alternative method for the evaluation of docking performance: RSR vs RMSD. J. Chem. Inf. Model, 48(7) : 1411-1422.
Zentgraf M,Steuber H,Koch C,La Motta C,Sartini S,Sotriffer CA,Klebe G .2009 .How reliable are current docking approaches for structurebased drug design? Lessons from aldose reductase. Angew. Chem, 46(19) : 3575-3578.